Skip to main content

Table 4 Lipid profiles of coronary artery disease cases and controls according to APOC3 3238 C/G polymorphisms

From: Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

 

CAD

P value

Controls

P value

CC

CG

GG

CC

CG

GG

TG (mg/dL)

162.3 ± 86.5

197.6 ± 90.4

253.9 ± 104.7

<0.001

138.7 ± 75.8

170.5 ± 80.6

224.6 ± 95.7

<0.001

TC (mg/dL)

199.4 ± 58.5

215.4 ± 62.7

196.3 ± 58.4

0.65

182.3 ± 47.1

213.8 ± 49.8

194.4 ± 48.7

0.74

HDL-C (mg/dL)

37.5 ± 11.1

40.8 ± 10.4

31.5 ± 9.8

0.56

37.4 ± 11.7

46.2 ± 14.5

41.7 ± 12.4

0.52

LDL-C (mg/dL)

127.1 ± 49.8

128.8 ± 49.8

105.7 ± 42.3

0.09

115.3 ± 34.9

130.6 ± 37.4

104.5 ± 32.7

0.34

VLDL-C (mg/dL)

34.8 ± 19.8

45.8 ± 24.1

59.1 ± 27.4

<0.001

29.6 ± 18.7

37.0 ± 20.1

48.2 ± 21.3

<0.001

ApoA1 (mg/dL)

124.6 ± 22.9

138.4 ± 25.6

125.2 ± 23.4

0.78

124.5 ± 22.1

135.6 ± 24.1

124.7 ± 21.8

0.68

ApoB (mg/dL)

88.3 ± 28.1

99.8 ± 30.1

89.1 ± 27.9

0.73

87.3 ± 24.2

97.7 ± 28.7

91.4 ± 25.7

0.82